Skip to content
The Nexus
BUSINESSJul 14 · 21:15 UTCWTOP DCWTOP Staff

VivoSim: Fiscal Q4 Earnings Snapshot

VivoSim Labs, Inc. (VIVS) reported a $5.8 million loss in its fiscal fourth quarter, with $2.21 per share loss and $40,000 in revenue. The company posted a $13.8 million annual loss, or $5.35 per share, with $131,000 in yearly revenue. The San Diego-based firm focuses on commercializing functional human tissue for drug and biological research.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
VivoSim Labs, Inc.organizationSan DiegoplaceAutomated InsightsorganizationZacks Investment Researchorganizationfunctional human tissue for drug and biological researchtopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting